Luke Mosel, DO
Anesthesiology · Shreveport, LANPI 1356846430
Payments from drug & device makers
What this record shows
This record is dominated by grants: $10,000 of the $14,221 with a category attached, or 70.3%. Medtronic accounts for 86.8% of it on its own, with 15 other manufacturers making up the rest. Reporting peaked in 2022 at $11,535 and has fallen 95.5% since, to $520 in 2025. Among anesthesiology clinicians in LA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 91 payments — averaging $156.27 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medtronic$12K
- Boston Scientific$1K
- Forte Bio-pharma LLC$162
- Collegium Pharmaceutical, Inc.$123
- Curonix LLC$98
- Relievant Medsystems, Inc.$87
- plus $294 from 10 others
What the payments were for
- Grants$10,00070%
- Travel & lodging$1,65612%
- Food & beverage$2,56518%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medtronic | 51 | $12,344 |
| Boston Scientific | 10 | $1,113 |
| Forte Bio-pharma LLC | 9 | $162 |
| Collegium Pharmaceutical, Inc. | 7 | $123 |
| Curonix LLC | 1 | $98 |
| Relievant Medsystems, Inc. | 1 | $87 |
| Stimwave Technologies Incorporated | 1 | $68 |
| Saluda Medical Americas, Inc. | 3 | $62 |
| ZOLL Respicardia, Inc. | 1 | $27 |
| Pacira Pharmaceuticals Incorporated | 1 | $25 |
| Averitas Pharma Inc. | 1 | $23 |
| Idorsia Pharmaceuticals US Inc | 1 | $20 |
| Merck | 1 | $18 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 1 | $18 |
| IBSA Pharma Inc. | 1 | $18 |
| Avanos Medical | 1 | $16 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- ACTIVA PC$10,000
- INTELLIS ADAPTIVESTIM$1,123
- Superion Indirect Decompression System$241
- INCEPTIV$111
How this compares
$14,221 in reported general payments places this provider in the 95th percentile of 497 anesthesiology providers in Louisiana.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| BelbucaBuprenorphine Hcl | 179 | $158,828 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 811 | $76,670 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 2,221 | $67,255 |
| Buprenorphine | 214 | $61,931 |
| BelsomraSuvorexant | 109 | $46,773 |
| Xtampza ErOxycodone Myristate | 47 | $26,620 |
| NucyntaTapentadol Hcl | 15 | $16,562 |
| LinzessLinaclotide | 27 | $14,386 |
| OxycontinOxycodone Hcl | 26 | $14,383 |
| MovantikNaloxegol Oxalate | 34 | $13,492 |
| QuliptaAtogepant | 12 | $13,383 |
| Oxycodone Hcl | 591 | $10,951 |
| Gabapentin | 485 | $8,266 |
| Morphine Sulfate ErMorphine Sulfate | 272 | $6,735 |
| Lidocaine | 77 | $6,687 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Collegium Pharmaceutical, Inc.Belbuca, Xtampza Er, Nucynta | $123 | $202,010241 claims |
| MerckBelsomra | $18 | $46,773109 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 497 anesthesiology providers in Louisiana.
Other anesthesiology in Shreveport
- Keith MayfieldShreveport$32K
- Caroline CarrollShreveport$26K
- Aya MouhaffelShreveport$20K
- Richard FairShreveport$17K
- Wendy BernsteinShreveport$16K
- Andrew LarsonShreveport$11K
- Debbie ChandlerShreveport$5K
- Brian BernhardtShreveport$4K
- George MychaskiwShreveport$2K
- Michael FranklinShreveport$2K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.